Clinical Trials on Normal Subjects

Total 4481 results

Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Dapagliflozin Tablet 10 mg Relative to Forxiga® Tablets 10 mg (DAP-030-23)

Healthy Subjects
Bio-innova Co., Ltd

Not yet recruiting

Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg (TIC-025-23)

Healthy Subjects
Cardenal Herrera University

Recruiting

Intramuscular Temperature on the Echo-textural Characteristics

Healthy Subjects

Spain
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

Safety and Tolerance Study of IBI355 in Health Volunteers

Healthy Subjects

China
Vigonvita Life Sciences

Recruiting

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Healthy Subjects

China
ImmunityBio, Inc.

Recruiting

Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Healthy Subjects

United States
Edgewise Therapeutics, Inc.

Recruiting

A Study of EDG-7500 in Healthy Adults

Healthy Subjects

United States
Centre Hospitalier Universitaire de Liege

Recruiting

Peri-Implant Soft Tissue Integration in Humans: Influence of Material

Healthy Subjects

Belgium
Shanghai Vinnerna Biosciences Co., Ltd.
Sponsor GmbH

Recruiting

The Mass Balance Study of [14C]JT001

Healthy Subjects

China
Celltrion

Recruiting

Compare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects

Healthy Subjects

Korea, Republic of
Dizal Pharmaceuticals

Recruiting

Drug-drug Interactions Between AZD4205 and Itraconazole/Carbamazepine

Healthy Subjects

United States
Celltrion

Recruiting

A Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects

Healthy Subjects

Korea, Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of SYHA1805 in Healthy Subjects

Healthy Subjects
CSPC Ouyi Pharmaceutical Co., Ltd.

Recruiting

The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects

Healthy Subjects

China
Indiana University
Purdue University

Recruiting

Effect of Stimulation on the Vagus Nerve

Healthy Subjects

United States
Russian Academy of Medical Sciences
State Scientific Centre of Coloproctology, Russian Federation; Federal Research...

Recruiting

Normative Metrics of High-Resolution Anorectal Manometry With the Use of Solid-State Catheter in a Healthy Russian Cohort

Healthy Subjects

Russian Federation
Jacobio Pharmaceuticals Co., Ltd.

Completed

A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects

Healthy Subjects

China
Alebund Pharmaceuticals

Completed

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants

Healthy Subjects

China
OrsoBio, Inc

Completed

A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants

Healthy Subjects

New Zealand
Örebro University, Sweden
Region Örebro County

Active, not recruiting

Spatial Analysis of the Intestinal Microbiota in Healthy Subjects

Healthy Subjects

Sweden
KBP Biosciences
Parexel

Completed

Study of KBP-7072 in Healthy Male and Female Subjects

Healthy Subjects

United States
Chong Kun Dang Pharmaceutical

Completed

Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

Healthy Subjects

United Kingdom
Chrysea Labs Lda

Active, not recruiting

Metabolic Responses to Spermidine Supplementation.

Healthy Subjects

United States
VectivBio AG

Completed

Evaluation of Apraglutide on Gastric Emptying

Healthy Subjects

Netherlands
Guangzhou JOYO Pharma Co., Ltd

Completed

Evaluation of Safety, Tolerability, PK/PD, and Metabolism of Single-Dose Singletine(DC407) in Adults

Healthy Subjects

China
Seoul National University Hospital
Ensol Biosciences, Inc.

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects

Healthy Subjects

Korea, Republic of
UNEEG Medical A/S

Completed

Safety and Performance of Short- and Long-term Baseplates for Attaching the Marco Recorder

Healthy Subjects

Denmark
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study of IBI351 in Healthy Subjects

Healthy Subjects

China
Vigonvita Life Sciences

Completed

A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

Healthy Subjects

China
BeBetter Med Inc

Completed

Study of Orally Administered BEBT-503 in Healthy Subjects

Healthy Subjects

Australia
CTI BioPharma
Covance

Completed

Drug-Interaction Study to Evaluate the Effect of Rifampin, a Potent CYP3A4 Inducer, on the Systemic Exposure of Pacritinib in Healthy Subjects

Healthy Subjects

United States
Taisho Pharmaceutical Co., Ltd.

Completed

A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly Subjects

Healthy Subjects

Japan
Portola Pharmaceuticals

Completed

A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers

Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd.

Completed

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers in Fed Condition

Healthy Subjects

Korea, Republic of
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

A Study to Evaluate the Effect of Different Meal Types on the Pharmacokinetics of DBPR108 in Healthy Subjects

Healthy Subjects

China
Shanghai Vinnerna Biosciences Co., Ltd.

Withdrawn

Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets

Healthy Subjects

Australia
Cairo University

Completed

Influence of Different Ankle Positions on Nerve Conduction Parameters of Deep Peroneal Nerve

Healthy Subjects

Egypt
BioLineRx, Ltd.
Celerion

Completed

Study to Investigate the Effect of BL-8040 (Motixafortide) on the QTc Interval in Healthy Subjects

Healthy Subjects

United States
Sunshine Lake Pharma Co., Ltd.

Completed

Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114

Healthy Subjects

China
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-132577 Can Affect Rosuvastatin's Fate in the Body (Amount and Time of Presence in the Blood)

Healthy Subjects

Czechia
Idorsia Pharmaceuticals Ltd.

Completed

Bioequivalence Study of Different Aprocitentan Tablet Formulations

Healthy Subjects

Czechia
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects

Healthy Subjects

Germany
Taisho Pharmaceutical Co., Ltd.

Completed

A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Drug-drug Interaction Study With TS-142 in Healthy Adult Subjects (Concomitant Administration of Itraconazole)

Healthy Subjects

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

Healthy Subjects

Japan
Nantes University Hospital

Completed

Modeling Variation of the Objective Mental Workload for Tasks Requiring Different Cognitive Functions.

Healthy Subjects

France
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Single Dose Tolerability and Pharmacokinetics of IBI112 in Healthy Subjects

Healthy Subjects

China
Future University in Egypt

Completed

Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt
Future University in Egypt

Completed

Bioequivalence Study of Etoricoxib in Healthy Adult Subjects Under Fasting Condition

Healthy Subjects

Egypt

3

Subscribe